Fabio
82 lines
5.4 KiB
Markdown
82 lines
5.4 KiB
Markdown
---
|
||
type: "Bill"
|
||
title: "Drugs, Prescription - As enacted, authorizes only a licensed physician to prescribe a buprenorphine product for an FDA-approved use in recovery or medication-assisted treatment; prohibits healthcare providers not licensed as physicians, and who are otherwise permitted to prescribe Schedule II or III drugs, from prescribing a buprenorphine product for the treatment of opioid use disorder unless the provider meets certain criteria; authorizes the health facilities commission to inspect facilities for compliance; requires the commission to report violations to the appropriate licensing authority. - Amends TCA Title 33; Title 53; Title 63 and Title 68."
|
||
description: "Drugs, Prescription - As enacted, authorizes only a licensed physician to prescribe a buprenorphine product for an FDA-approved use in recovery or medication-assisted treatment; prohibits healthcare providers not licensed as physicians, and who are otherwise permitted to prescribe Schedule II or III drugs, from prescribing a buprenorphine product for the treatment of opioid use disorder unless the provider meets certain criteria; authorizes the health facilities commission to inspect facilities for compliance; requires the commission to report violations to the appropriate licensing authority. - Amends TCA Title 33; Title 53; Title 63 and Title 68."
|
||
jurisdiction: "us/states/tn"
|
||
legislature: "Tennessee General Assembly"
|
||
session: "113"
|
||
identifier: "SB 2297"
|
||
citation: "Tennessee SB 2297 (113)"
|
||
classification: ["bill"]
|
||
subjects: ["Drugs", "Prescription"]
|
||
status: "enacted"
|
||
primary_sponsors: ["Haile"]
|
||
version_count: 3
|
||
action_count: 23
|
||
vote_count: 3
|
||
first_action: "2024-01-30"
|
||
last_action: "2024-05-13"
|
||
source: "openstates"
|
||
source_identifier: "ocd-bill/c9752839-bd22-492a-bb33-f5b1b128d402"
|
||
source_url: "http://wapp.capitol.tn.gov/apps/BillInfo/default.aspx?BillNumber=SB2297&GA=113"
|
||
source_hash: "4b14aa3117ae2f0fd1e70f31bdeb7e4f1604be1b7da9316a1fde2ebe7aca4f87"
|
||
vintage: "2026-07-01"
|
||
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
|
||
retrieved_at: "2026-07-06"
|
||
confidence: "reported"
|
||
tags: ["legislation", "bill", "us-tn"]
|
||
---
|
||
|
||
# Tennessee SB 2297 (113) — Drugs, Prescription - As enacted, authorizes only a licensed physician to prescribe a buprenorphine product for an FDA-approved use in recovery or medication-assisted treatment; prohibits healthcare providers not licensed as physicians, and who are otherwise permitted to prescribe Schedule II or III drugs, from prescribing a buprenorphine product for the treatment of opioid use disorder unless the provider meets certain criteria; authorizes the health facilities commission to inspect facilities for compliance; requires the commission to report violations to the appropriate licensing authority. - Amends TCA Title 33; Title 53; Title 63 and Title 68.
|
||
|
||
## Version chain
|
||
|
||
The bill's text revisions, in order — the diff chain from filing to enrollment.
|
||
|
||
1. **Amendment HA0776** (committee substitute) — [source](https://www.capitol.tn.gov/Bills/113/Amend/HA0776.pdf)
|
||
2. **Amendment SA0800** (committee substitute) — [source](https://www.capitol.tn.gov/Bills/113/Amend/SA0800.pdf)
|
||
3. **Current Version** (committee substitute) — [source](https://www.capitol.tn.gov/Bills/113/Bill/SB2297.pdf)
|
||
|
||
## Votes
|
||
|
||
- SENATE HEALTH AND WELFARE COMMITTEE: Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 6, Nays 3 PNV 0 3/19/2024 Passed — **6–3** (pass) · upper
|
||
- FLOOR VOTE: REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATION 4/15/2024 Passed (1) — **88–5** (pass) · lower
|
||
- FLOOR VOTE: as Amended Third Consideration 3/28/2024 Passed (1) — **27–3** (pass) · upper
|
||
|
||
## Sponsors
|
||
|
||
- Haile — primary (person)
|
||
|
||
## Timeline
|
||
|
||
The legislative action history — every referral, reading, and vote.
|
||
|
||
- **2024-01-30** Filed for introduction `filing`
|
||
- **2024-01-31** Introduced, Passed on First Consideration `introduction`
|
||
- **2024-02-01** Passed on Second Consideration, refer to Senate Health and Welfare Committee `passage`
|
||
- **2024-03-13** Placed on Senate Health and Welfare Committee calendar for 3/19/2024
|
||
- **2024-03-13** Sponsor change. `sponsorship`
|
||
- **2024-03-19** Recommended for passage with amendment/s, refer to Senate Calendar Committee Ayes 6, Nays 3 PNV 0
|
||
- **2024-03-20** Sponsor(s) Added. `sponsorship`
|
||
- **2024-03-26** Placed on Senate Regular Calendar for 3/28/2024
|
||
- **2024-03-28** Sponsor(s) Added. `sponsorship`
|
||
- **2024-03-28** Engrossed; ready for transmission to House `receipt`
|
||
- **2024-03-28** Passed Senate as amended, Ayes 27, Nays 3 `passage`
|
||
- **2024-03-28** Senate adopted Amendment (Amendment 1 - SA0800)
|
||
- **2024-04-01** Rcvd. from S., held on H. desk.
|
||
- **2024-04-15** Passed H., Ayes 88, Nays 5, PNV 0 `passage`
|
||
- **2024-04-15** Am. withdrawn. (Amendment 1 - HA0776) `amendment-withdrawal`
|
||
- **2024-04-15** Subst. for comp. HB. `substitution`
|
||
- **2024-04-16** Signed by Senate Speaker `passage`
|
||
- **2024-04-16** Enrolled and ready for signatures `enrolled`
|
||
- **2024-04-18** Signed by H. Speaker `passage`
|
||
- **2024-04-19** Transmitted to Governor for action. `executive-receipt`
|
||
- **2024-05-01** Signed by Governor. `executive-signature`
|
||
- **2024-05-13** Effective date(s) 05/01/2024
|
||
- **2024-05-13** Pub. Ch. 857
|
||
|
||
## Source
|
||
|
||
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/c9752839-bd22-492a-bb33-f5b1b128d402`. Confidence: reported (aggregated from official Tennessee legislature records).
|
||
|